Markel Group Inc. (MKL) Stock Analysis
Falling Knife setup
Financial Services · Insurance - Property & Casualty
Sell if holding. Analyst target reached at $1759.29 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: concentrated equity securities portfolio (70.0%).
Markel Group is a holding company anchored by Markel Insurance, which provides specialty P&C insurance, plus Markel Ventures owning diverse industrial and consumer businesses. It generated $15.5B in operating revenues in 2025 with $18.6B in shareholders' equity, compounding... Read more
Sell if holding. Analyst target reached at $1759.29 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: concentrated equity securities portfolio (70.0%). Chart setup: Death cross, below all MAs, RSI 26, MACD bearish. Score 4.2/10, moderate confidence.
Passes 4/7 gates (clean insider activity, no SEC red flags, earnings proximity 90d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductconcentrated equity securities portfolio70%10-K Item 1A: 'Equity securities were 70% of our shareholders' equity at December 31, 2025... Our portfolio of equity securities is concentrated in particular issuers and industries'
Material Events(8-K, last 90d)
- 2026-02-26Item 5.02MEDIUMEVP/COO Michael R. Heaton departing March 23, 2026 per mutual agreement, with severance. Simon Wilson appointed EVP/CEO Markel Insurance; Andrew Crowley appointed EVP/President Markel Ventures. COO role not replaced directly.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Revenue shrinking — -16.9% YoY. Growth thesis broken unless recovery story develops.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $1759.29 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: concentrated equity securities portfolio (70.0%). Chart setup: Death cross, below all MAs, RSI 26, MACD bearish. Prior stop was $1667.83. Score 4.2/10, moderate confidence.
Take-profit target: $1774.28 (+1.1% upside). Prior stop was $1667.83. Stop-loss: $1667.83.
Concentration risk — Product: concentrated equity securities portfolio (70.0%); Analyst target reached - limited upside remaining; Weak overall score: 4.2/10.
Markel Group Inc. trades at a P/E of 12.7 (forward 13.8). TrendMatrix value score: 7.0/10. Verdict: Sell.
13 analysts cover MKL with a consensus score of 2.5/5. Average price target: $2039.
What does Markel Group Inc. do?Markel Group is a holding company anchored by Markel Insurance, which provides specialty P&C insurance, plus Markel...
Markel Group is a holding company anchored by Markel Insurance, which provides specialty P&C insurance, plus Markel Ventures owning diverse industrial and consumer businesses. It generated $15.5B in operating revenues in 2025 with $18.6B in shareholders' equity, compounding capital through insurance float invested heavily in equities and by acquiring operating businesses.